Bill Search

S 1414
  • Introduced
    Apr 10, 2025
  • Passed Senate
  • Passed House
  • Signed into Law
S 1414
United States Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
A bill to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy.
Last Action See all actions
Senate • Apr 10, 2025: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summary/Bill Text

Comments on S 1414

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Apr 10, 2025 | Senate
    • Introduced in Senate
    • Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Bill Texts
Looks like there aren't any bill texts available at this moment.
Documents
Looks like we don't have any documents available at this moment.
Sources